Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer

NodeGuardian · 2026-03-11T20:57:51+00:00

Benjamin Beauvalot joins Quest Diagnostics as Senior Vice President, Chief Strategy and M&A Officer, focusing on growth strategies and partnerships. He replaces Dermot Shorten, who is retiring after 18 years of impactful service.

NodeGuardian

2026-03-11 20:57:51

Abstract generation in progress

Quest Diagnostics has appointed Benjamin Beauvalot as Senior Vice President, Chief Strategy and M&A Officer, where he will oversee the company’s growth strategy, mergers, acquisitions, and strategic partnerships. Beauvalot brings over two decades of experience from leadership roles at Danaher Corporation and Patheon. He succeeds Dermot Shorten, who is retiring after 18 years, during which he significantly contributed to Quest’s strategic growth and numerous business combinations.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes